Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions: Anemia; Renal Insufficiency, ChronicInterventions: Drug: Molidustat (BAY 85-3934); Biological: Epoetin alfa/betaSponsor: BayerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2013 Category: Research Source Type: clinical trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions: Anemia; Renal Insufficiency, ChronicInterventions: Drug: Molidustat (BAY 85-3934); Biological: Epoetin alfa/betaSponsor: BayerRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2013 Category: Research Source Type: clinical trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions: Anemia; Renal Insufficiency, ChronicInterventions: Drug: Molidustat (BAY 85-3934); Biological: Epoetin alfa/betaSponsor: BayerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2013 Category: Research Source Type: clinical trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions: Anemia; Renal Insufficiency, ChronicInterventions: Drug: Molidustat (BAY 85-3934); Biological: Epoetin alfa/betaSponsor: BayerRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2013 Category: Research Source Type: clinical trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions: Anemia; Renal Insufficiency, ChronicInterventions: Drug: Molidustat (BAY 85-3934); Biological: Epoetin alfa/betaSponsor: BayerRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2013 Category: Research Source Type: clinical trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions: Anemia; Renal Insufficiency, ChronicInterventions: Drug: Molidustat (BAY 85-3934); Biological: Epoetin alfa/betaSponsor: BayerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2013 Category: Research Source Type: clinical trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Conditions: Anemia; Chronic Kidney Disease (CKD)Interventions: Drug: HX575 epoetin alfa; Drug: US-licensed epoetin alfaSponsor: SandozCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2012 Category: Research Source Type: clinical trials